Suppr超能文献

肾功能与动脉僵硬度相关,并可预测冠心病患者的预后。

Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease.

作者信息

Ilyas B, Dhaun N, Markie D, Stansell P, Goddard J, Newby D E, Webb D J

机构信息

Clinical Pharmacology Unit, University of Edinburgh,The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, UK.

出版信息

QJM. 2009 Mar;102(3):183-91. doi: 10.1093/qjmed/hcn171. Epub 2009 Jan 7.

Abstract

BACKGROUND

Arterial stiffness (AS) is associated, and a predictor of, outcome in patients with cardiovascular and renal disease.

AIM

In this study, we estimated glomerular filtration rate (eGFR) and measured indices of AS in patients with suspected coronary artery disease (CAD), and assessed their predictive value on outcome.

DESIGN

Prospective cohort study.

METHODS

AS was measured using pulse wave velocity (PWV) and pulse wave analysis in patients with no known renal disease who had recently undergone coronary angiography. Renal function was assessed using serum creatinine concentration creat and eGFR (Cockcroft & Gault, C&G). The primary endpoint was a combination of hospitalization due to cardiovascular disease and all-cause mortality.

RESULTS

Two hundred eighty-four subjects (210 men, 74 women, mean age 62 years) were followed-up for a mean of 1.5 years. PWV was negatively associated with eGFR (r(2) = 0.09, P < 0.001), even in patients with an eGFR > or =60 ml/min/m(2) (r(2) = 0.04, P < 0.01). PWV was determined by age, heart rate, systolic blood pressure, body mass index and creat (r(2) = 0.38, P < 0.001). A lower eGFR (P < 0.01), PWV above the median (P < 0.05) and degree of CAD (P < 0.001) predicted a shorter time to the primary endpoint. eGFR and degree of CAD remained independent determinants of outcomes (P < 0.01), even in patients with normal renal function (P < 0.01).

CONCLUSION

This study suggests that even minor reductions in eGFR, within the normal range, are an additional independent risk marker in patients with CAD.

摘要

背景

动脉僵硬度(AS)与心血管和肾脏疾病患者的预后相关,且是其预后的一个预测指标。

目的

在本研究中,我们估算了疑似冠心病(CAD)患者的肾小球滤过率(eGFR)并测量了AS指标,评估了它们对预后的预测价值。

设计

前瞻性队列研究。

方法

在近期接受冠状动脉造影且无已知肾脏疾病的患者中,使用脉搏波速度(PWV)和脉搏波分析测量AS。使用血清肌酐浓度肌酐和eGFR(Cockcroft & Gault,C&G)评估肾功能。主要终点是心血管疾病住院和全因死亡率的综合情况。

结果

284名受试者(210名男性,74名女性,平均年龄62岁)平均随访1.5年。PWV与eGFR呈负相关(r(2)=0.09,P<0.001),即使在eGFR≥60 ml/min/m(2)的患者中也是如此(r(2)=0.04,P<0.分)。PWV由年龄、心率、收缩压、体重指数和肌酐决定(r(2)=0.38,P<0.001)。较低的eGFR(P<0.01)、PWV高于中位数(P<0.05)和CAD程度(P<0.001)预测到达到主要终点的时间较短。即使在肾功能正常的患者中,eGFR和CAD程度仍是预后的独立决定因素(P<0.01)。

结论

本研究表明,即使在正常范围内eGFR有轻微降低,也是CAD患者额外的独立风险标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验